83 related articles for article (PubMed ID: 1674933)
1. Ovarian stimulation concomitant with pituitary-ovarian axis suppression by different GnRH agonists.
Insler V; Lunenfeld E; Potashnik G; Levy J
Int J Fertil; 1991; 36(2):121-7. PubMed ID: 1674933
[TBL] [Abstract][Full Text] [Related]
2. The effect of different LH-RH agonists on the levels of immunoreactive gonadotropins.
Insler V; Lunenfeld E; Potashnik G; Levy J
Gynecol Endocrinol; 1988 Dec; 2(4):305-12. PubMed ID: 2976572
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
4. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
[TBL] [Abstract][Full Text] [Related]
5. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
6. The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).
Gonen Y; Dirnfeld M; Goldman S; Koifman M; Abramovici H
J In Vitro Fert Embryo Transf; 1991 Oct; 8(5):254-9. PubMed ID: 1836810
[TBL] [Abstract][Full Text] [Related]
7. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
[TBL] [Abstract][Full Text] [Related]
8. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER
Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
[TBL] [Abstract][Full Text] [Related]
9. Role of gonadotropin releasing hormone agonists in ovulation induction.
Dodson WC
J Reprod Med; 1989 Jan; 34(1 Suppl):76-80. PubMed ID: 2497247
[TBL] [Abstract][Full Text] [Related]
10. GnRH analogs: depot versus short formulations.
Dal Prato L; Borini A; Cattoli M; Bonu MA; Sereni E; Flamigni C
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115 Suppl 1():S40-3. PubMed ID: 15196715
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women.
Dodson WC; Walmer DK; Hughes CL; Yancy SE; Haney AF
Obstet Gynecol; 1991 Aug; 78(2):187-90. PubMed ID: 1906152
[TBL] [Abstract][Full Text] [Related]
12. [GnRH agonists in the ovulation stimulation scheme for in vitro fertilization].
Roztocil A; Pilka L; Holubová M
Cesk Gynekol; 1989 Dec; 54(10):776-82. PubMed ID: 2534286
[No Abstract] [Full Text] [Related]
13. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
Tesarik J; Hazout A; Mendoza-Tesarik R; Mendoza N; Mendoza C
Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
[TBL] [Abstract][Full Text] [Related]
15. Endocrine profiles and luteal function during GnRH-analogue/HMG therapy.
Braendle W; Lindner C; Lichtenberg V; Goepel E; Bettendorf G
Hum Reprod; 1989 Nov; 4(8 Suppl):121-6. PubMed ID: 2533217
[TBL] [Abstract][Full Text] [Related]
16. Induction of ovulation with pulsatile gonadotropin releasing hormone (GnRH) in anovulatory women.
Cignitti M; Mazzarini A; Pini A; Garzetti GG; Romanini C
Acta Eur Fertil; 1990; 21(5):235-8. PubMed ID: 2132474
[TBL] [Abstract][Full Text] [Related]
17. Suppression with gonadotropin-releasing hormone analogues prior to stimulation with gonadotropins: comparison of three protocols.
Lipitz S; Ben-Rafael Z; Dor J; Shalev J; Elenbogen A; Levran D; Serr DM; Mashiach S
Gynecol Obstet Invest; 1989; 28(1):31-4. PubMed ID: 2528497
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
Elkind-Hirsch KE; Anania C; Malinak R
J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
[TBL] [Abstract][Full Text] [Related]
19. GnRH antagonists in ovarian stimulation for IVF.
Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin releasing hormone agonists and the induction or augmentation of ovulation.
Martin MC
J Reprod Med; 1989 Dec; 34(12 Suppl):1034-8. PubMed ID: 2533619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
